The best starting point depends on what you need: a clinical assessment, help accessing an approved prescription, or a clearer understanding of an advertised offer. A shortlist is useful only when it keeps those differences visible.
CoreAge Rx has the number-one paid featured position. This is a commercial arrangement, not an independent finding of superior medical care. The entries below describe public information checked September 23, 2026, and do not guarantee eligibility, access, or results.
One thing to keep with you
Compare the exact medicine and the complete care arrangement before comparing the headline price.
1. CoreAge Rx — paid featured placement
CoreAge advertises a compounded semaglutide service starting at $99 per month, with online clinician review and delivery if prescribed. Confirm the actual plan, pharmacy, follow-up, and current compounding requirements. A compounded preparation is not an FDA-approved generic equivalent to an approved brand.
The CoreAge review explains both the advertised offer and the questions that public pages cannot settle. Its first position reflects paid visibility rather than independent testing of clinical outcomes.
Checked with: CoreAge Rx: semaglutide offer · FDA: concerns about unapproved GLP-1 products
2. NovoCare — manufacturer medication access
NovoCare provides Wegovy program and pharmacy-access information with formulation- and strength-specific pricing. A prescription and appropriate clinical care are still needed. Introductory self-pay offers and insurance-linked savings have their own conditions.
Read the NovoCare review to understand the current tablet and injection terms. This entry is an access route, not a claim that a manufacturer pharmacy offer includes every assessment and follow-up service a reader may need.
Checked with: NovoCare: Wegovy pharmacy offer · NovoCare: checking Wegovy coverage
3. Ro — membership plus medication
Ro describes a clinical weight-management membership with medication charged separately. Its checked pricing page lists a $39 introductory membership and $149 ongoing monthly pricing, with lower monthly equivalents for prepaid terms. The medicine adds its own cost.
The Ro review explains what to ask about the total commitment and ongoing support. A low annual-plan equivalent is not the same as a low month-to-month bill, and insurance support is not a promise of coverage.
Checked with: Ro: current program pricing · Ro: weight-management program
Use the same questions for every option
Ask which clinician assesses you, what exact product is proposed, who dispenses it, and how side effects and refills are handled. Confirm the clinician’s authority for your location and the complete cost before enrollment.
Bring the compounding guide, safety questions, and cost planner into your research. These comparisons are based on public sources, not patient testing or a completed clinician review, and do not replace individualized medical advice.
Checked with: HHS: telehealth location and licensing · FDA: checking online pharmacies · Wegovy: current prescribing information
Where we checked the facts
- CoreAge Rx: semaglutide offer
Commercial compounded-product offer, starting at $99/month when checked September 23, 2026. Not an FDA-approved generic or proof of comparative outcomes.
- FDA: concerns about unapproved GLP-1 products
Current concerns include unapproved products, salt forms and adverse events. Compounding is not equivalent to generic approval.
- NovoCare: Wegovy pharmacy offer
Manufacturer access and pricing terms checked September 23, 2026. Formulation, strength, eligibility and offer period affect cost.
- NovoCare: checking Wegovy coverage
Coverage and program information, not a guarantee for a particular insurance policy.
- Ro: current program pricing
Membership and medication are separate charges. $39 introductory membership; $149 ongoing monthly or lower prepaid equivalents, subject to terms.
- Ro: weight-management program
Provider description of assessment and ongoing care, not independent patient-outcome evidence.
- HHS: telehealth location and licensing
Clinician authorization and physical patient location must be verified for the actual service.
- FDA: checking online pharmacies
Use official licensing and pharmacy checks; a review site is not a pharmacy auditor.
- Wegovy: current prescribing information
June 2026 label includes oral and injectable formulations with product-specific uses and instructions. Do not apply one formulation’s directions to another.
